Table 2

Pooled RRR* and 95% CI of folic acid supplement doses in the periconceptional period (first period)† of pregnancy among pregnant women, from the INMA Project, Spain (2003–2008)

Women who took FAS, n (%)Folic acid supplement use (in µg/day) during the first period†
400–999 (mean=433.0)<400, included non use (mean=141.8)≥1000 (mean=3104.6)
329 (14%)1336 (57%)666 (29%)
nnRRR* (95% CI)I2, %‡nRRR* (95% CI)I2, %‡
Maternal age, (years)
 ≤301617221.002811.00
 >301686140.90 (0.58 to 1.40)58.43851.31 (0.82 to 2.10)58.5
Maternal education
 Primary school or less653731.001221.00
 Secondary school1245631.06 (0.73 to 1.52)0.02831.31 (0.88 to 1.94)0.0
 University studies1404000.66 (0.44 to 0.98)27.32610.91 (0.59 to 1.39)24.4
Paternal education
 Primary school or less965251.002081.00
 Secondary school1645570.70 (0.51 to 0.95)0.03160.82 (0.59 to 1.15)0.0
 University studies692540.97 (0.65 to 1.45)0.01421.00 (0.65 to 1.54)0.0
Tobacco smoking†
 No28910611.005581.00
 Yes402751.63 (1.11 to 2.39)0.01081.36 (0.90 to 2.07)0.0
Alcohol consumption†
 No2519231.004601.00
 Yes784131.40 (1.02 to 1.92)39.12061.42 (1.01 to 1.98)19.2
Pre-pregnancy BMI
 <252419691.004991.00
 25–29.9602530.95 (0.67 to 1.33)0.01230.90 (0.62 to 1.30)19.9
 ≥30281140.89 (0.55 to 1.44)12.4440.79 (0.46 to 1.36)0.0
Planned pregnancy
 Yes31210511.005791.00
 No172854.20 (2.47 to 7.12)5.0872.66 (1.52 to 4.65)0.0
Parity
 02097441.003691.00
 ≥11205921.44 (1.08 to 1.91)0.02971.33 (0.98 to 1.80)0.0
Previous abortions
 No23110471.005041.00
 Yes982890.58 (0.43 to 0.77)45.51620.68 (0.50 to 0.94)42.0
Private gynaecologist†
 No1899231.004231.00
 Yes1404130.78 (0.52 to 1.17)53.02430.88 (0.42 to 1.88)84.2§
  • *Cohort-specific multinomial logistic models were combined using meta-analysis, the models were adjusted by all variables in the table.

  • †During the periconceptional stage from the preconception to the third month.

  • ‡We used the results from fixed effect meta-analysis model when I2 was <50% and from the random effects meta-analysis model when I2 was >50%.

  • §P Cochran <0.05 from test of heterogeneity.

  • BMI, body mass index; RRR, relative risk ratio.